Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

rasha medhat abdul-hady

Status: Unknown

Conditions: Placenta Accreta

Treatments: Diagnostic Test: Serum alpha-fetoproteine

Study type: Observational

Funder types: Other

Identifiers

NCT04082507

AFP_AP

Details and patient eligibility

About

The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.

Full description

in pregnant women withe previous cesarean section, placenta previa and ultrasonographic finding of an abnormally adherent placenta dose maternal serum alpha-fetoprotein predict prenataly the presence of morbid adherent placenta accurately?

Enrollment: 150 estimated patients

Sex: Female

Ages: 20 to 39 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• pregnant women with history of scarred uterus

  • plcenta previa covering the scar of previous caesarean section as diagnosed by 2DU/S
  • Gestational age from 28wks to full term

Exclusion criteria

• pregnant women with fetus with congenital anomalies

  • pregnant women with ovarian swelling
  • pregnant women with medical disease

Trial design

150 participants in 2 patient groups

Non_adherent plcenta

Description:

placenta separated within 15 minutes after delivery of fetus

Adherent placenta

Description:

placenta dosenot separated within 15 minutes after delivery of fetus

Treatment:

Diagnostic Test: Serum alpha-fetoproteine